Labiotech.eu

Inside Labiotech 23 Sep 2015

Labiotech.eu is 1 year old: Discover our Entrepreneurial Journey!

Hi there, Yesterday, with 30 guests from Berlin, we celebrated the first year of Labiotech.eu! Not only that we survived but we also have now more than 15,000 people visiting our website each month. Thank you all, that makes us the Europe’s leading digital media for Biotech! I am extremely proud of what we achieved and […]

September 23, 2015 - 5 minutesmins - By Philip Hemme

News and Trends 23 Sep 2015

British Bionic Pancreas controlled by iPhone to revolutionize Type I Diabetes treatment

It’s finally happened; a research team from the University of Cambridge (UK) has managed to develop a closed loop beta-cell based insulin delivery system for diabetes type I. This bionic pancreas prototype has been constructed for human trials using an iPhone app which monitors blood glucose levels. There are 3 components to the bionic pancreas; […]

September 23, 2015 - 3 minutesmins - By Dani Bancroft

News and Trends 23 Sep 2015

NovoCure, the Israeli tumor specialist announces NASDAQ €170M IPO

NovoCure, originally from Haifa (Israel) is planning an IPO on NASDAQ with a target of €170M to make from its 12.5M shares on offer. It is hoped this financial injection will further commercialize its FDA-approved tumor treating field (TTField) medical device Optune. NovoCure is a commercial stage oncology biotech specialising in trials for solid-tumor treatments. Founded […]

September 23, 2015 - 2 minutesmins - By Dani Bancroft

News and Trends 22 Sep 2015

Francis Crick Institute pushes to do human embryo research

The Francis Crick Institute from London has announced its application to conduct non-clinical purpose research on human embryos. The Francis Crick Institute is a cutting-edge collaboration of the UK’s leading medical research organisations: the Medical Research Council, Cancer Research UK, various London academic institutions and the Wellcome Trust. Currently still under construction, it is based in […]

September 22, 2015 - 2 minutesmins - By Dani Bancroft

News and Trends 22 Sep 2015

UniQure’s cure for rare Lysosomal disease ready for phase III trial

UniQure from the Netherlands has promising results for its enzyme replacement therapy phase Ib/II trial targeting a rare Lysosomal disease. This has granted fast-track approval to launch its phase III trial for children with Sanfilippo Type B (MPS-III) in collaboration with France’s Institut Pasteur. UniQure is the Amsterdam gene-therapy biotech with a lot going on. Last year […]

September 22, 2015 - 3 minutesmins - By Dani Bancroft

News and Trends 22 Sep 2015

Selvita moves in: The biggest Polish biotech on the Boston Block

Welcome to the US! Polish Selvita has announced its new US HQ in Cambridge (MA), which they hope will better integrate their drug-discovery work into the US market. Selvita, from Krakow (Poland) is the largest Polish biotech with 265+ employees, 86 of which hold PhDs. Having been built on offering pre-clinical services to over 50 US/EU […]

September 22, 2015 - 2 minutesmins - By Dani Bancroft

News and Trends 21 Sep 2015

Shire’s Adderall alternative granted EMA approval for EU

Intuniv, Shire‘s new anti-stimulatory product for children with attention-deficit hyperactivity disorder (ADHD) between 6-17 years old, is set to hit shelves in Europe following successful market approval by the European medicine agency (EMA). Shire, a pharma giant with a €23.5Bn market cap, dominates the ADHD market. Originally from Basingstoke (England), they also have bases in the […]

September 21, 2015 - 2 minutesmins - By Dani Bancroft

News and Trends 21 Sep 2015

How can we increase the nutritional value of GMO-rice whilst cutting greenhouse emissions?

New GMO rice variety has an increased starch content coupled with low greenhouse gas emissions. By making these GM rices more eco-friendly as well as improving their nutritional value, this research could potentially sway the public and political stigma against this life-altering technology, in the mission to save millions. As we all know, grains such as Golden […]

September 21, 2015 - 3 minutesmins - By Joachim Eeckhout

News and Trends 19 Sep 2015

Swiss Biotech Boom: Life sciences startups dominate top 100 awards

Exciting news for the Swiss biotech frontline! The TOP 100 Start-Up award is hosted by Startup.ch the Swiss start-up platform (through IFJ Institut für Jungunternehmen) in collaboration with the major paper Handelszeitung and PME Magazine, ranking the 100 most promising new start up companies. Of these 100, a whopping 68 of these start-ups are in the […]

September 19, 2015 - 2 minutesmins - By Dani Bancroft

News and Trends 18 Sep 2015

Discover the Worlds first Bioactive Toilet Paper from Italy

Papernet biotech (part of the Italian Sofidel Group) launched their biological toilet paper back in 2007 as an answer to our hygiene based ecological crisis. With over 7Bn rolls produced per year in the US alone, Papernet is an award-winning subsidiary of the hygiene giant’s portfolio. The invention of using paper for hygiene purposes was […]

September 18, 2015 - 2 minutesmins - By Joachim Eeckhout

News and Trends 18 Sep 2015

Servier to revolutionize Diabetes treatment thanks to Intarcia’s successful Phase III

Treatment of diabetes hasn’t changed so much since the development of first human insulin by Genentech. But Boston-based Intarcia (a partner of Servier and one of the 9 billion-dollar Biotech startups worldwide) has just published positive phase III results of its implantable device aiming at changing how type 2 diabetes are treated. November 2014: I thought […]

September 18, 2015 - 3 minutesmins - By Philip Hemme

News and Trends 17 Sep 2015

France’s leading Female Bio-entrepreneur joins board of Abivax

Dominique Costantini is one of France’s leading biotech figures, with over 20 years experience on boards, partnerships and business backing in some of the biotech industries leading brands. With a medical background specializing in immunology (from Paris V University), Costantini co-founded oncology focused Onxeo in 1997. Formerly known as BioAlliance Pharma, this biotech went public […]

September 17, 2015 - 2 minutesmins - By Dani Bancroft

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Labiotech.eu is 1 year old: Discover our Entrepreneurial Journey!

British Bionic Pancreas controlled by iPhone to revolutionize Type I Diabetes treatment

NovoCure, the Israeli tumor specialist announces NASDAQ €170M IPO

Francis Crick Institute pushes to do human embryo research

UniQure’s cure for rare Lysosomal disease ready for phase III trial

Selvita moves in: The biggest Polish biotech on the Boston Block

Shire’s Adderall alternative granted EMA approval for EU

How can we increase the nutritional value of GMO-rice whilst cutting greenhouse emissions?

Swiss Biotech Boom: Life sciences startups dominate top 100 awards

Discover the Worlds first Bioactive Toilet Paper from Italy

Servier to revolutionize Diabetes treatment thanks to Intarcia’s successful Phase III

France’s leading Female Bio-entrepreneur joins board of Abivax

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!